Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Orchestra BioMed Holdings, Inc. (OBIO) had Revenue of $0.84M for the most recently reported fiscal quarter, ending 2025-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-06-30

Income Statement Financials
Revenue	$0.84M
Net Income	$-19.36M
Cost of Goods Sold	$0.05M
Gross Profit	$0.79M
Operating Expenses	$20.16M
Operating Income	$-19.33M
Non-Operating Income/Expense	$-0.04M
Pre-Tax Income	$-19.36M
Normalized Pre-Tax Income	$-19.36M
Income after Taxes	$-19.36M
Income from Continuous Operations	$-19.36M
Consolidated Net Income/Loss	$-19.36M
Normalized Income after Taxes	$-19.36M
EBIT	$-19.33M
EBITDA	$-19.20M
Weighted-Average Shares Outstanding (Basic)	38.39M
Weighted-Average Shares Outstanding (Diluted)	38.39M
Earnings per Share (EPS) (Basic)	$-0.50
Earnings per Share (EPS) (Diluted)	$-0.50
Balance Sheet Financials
Current Assets	$35.88M
Property, Plant, and Equipment	$1.37M
Long-Term Assets	$6.94M
Total Assets	$42.83M
Current Liabilities	$17.06M
Long-Term Debt	$14.38M
Long-Term Liabilities	$25.47M
Total Liabilities	$42.53M
Common Equity	$0.29M
Tangible Shareholders Equity	$0.29M
Shareholders Equity	$0.29M
Common Shares Outstanding	38.64M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-32.14M
Cash Flow from Investing Activities	$29.36M
Cash Flow from Financial Activities	$-0.72M
Beginning Cash	$22.26M
End Cash	$18.75M
Increase/Decrease in Cash	$-3.51M
Stock-Based Compensation	$6.21M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.10
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.98
Debt to Equity Ratio	48.76
Gross Margin	94.50%
Operating Margin	-2311.84%
EBIT Margin	-2311.84%
EBITDA Margin	--
Pre-Tax Profit Margin	-2316.15%
Profit Margin	-2316.15%
Free Cash Flow	$-32.29M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.02
Inventory Turnover	0.25
Receiveable Turnover	10.07
Days Sales in Receivables	8.94
Return on Equity	-6563.91%
Return on Tangible Equity	-6563.68%
Return on Assets	-45.21%
Return on Investments	-131.91%
Book Value Per Share	$0.01
Free Cash Flow per Share	$-0.84
Operating Cash Flow per Share	$-0.84

Data from Zacks Investment Research, Inc.